Le Lézard
Classified in: Business
Subject: TNM

Private Equity Firm, Summer Street Capital Announces Recent Exits


BUFFALO, N.Y., Sept. 24, 2018 /PRNewswire/ -- Summer Street Capital Partners, LLC, a Buffalo, NY-based private equity fund, announces that the firm enjoyed an active first half of 2018, disclosing the successful sale of several platform investments.  Summer Street Capital focuses on a buy-and-build strategy, investing in companies with above-average opportunities for organic and acquisition growth.  Based on significant growth and success during its hold periods, Summer Street took advantage of an active M&A market to complete the sale of several portfolio companies. 

Summer Street Capital Partners, LLC Coporate Logo. (PRNewsFoto/Summer Street Capital Partners, LLC)

In Q2, Summer Street Capital exited their investment in Multisorb Technologies, a Buffalo, NY-based manufacturer of active packaging solutions that it had acquired in 2014.  Over the course of a three-and-a-half-year ownership period, Multisorb invested in innovation, production, and international expansion, resulting in earnings growth and attractive future growth opportunities.

Most recently, Summer Street Capital exited its investment in Dwellworks.  Headquartered in Cleveland, OH, Dwellworks is a provider of global mobility support solutions.  Summer Street Capital invested in Dwellworks in 2014 to facilitate an aggressive organic growth and acquisition strategy. Through a collaborative effort, Dwellworks significantly grew operations and service offerings, enabling them to better serve customers across North America, Europe and Asia.

Baird's Global Investment Banking Group advised Summer Street Capital on the sale of both Multisorb Technologies and Dwellworks.  

Earlier in the year, Summer Street Capital also exited Buffalo, NY-based Palladian Health, a managed care services company.  Managing Partner, Brian D'Amico commented, "We are pleased to have completed several exits so far in 2018.  Effectively executing a buy-and-build strategy requires alignment with talented and committed management teams.  We are grateful to our management partners for their hard work and dedication to excellence." 

About Summer Street Capital Partners, LLC

Summer Street Capital Partners, LLC, founded in 1999, is a Buffalo, NY-based private equity fund manager with committed capital focused on investing in small and middle market companies.  The firm invests alongside talented managers, bringing capital and resources to support acquisitions and aggressive growth strategies.  Summer Street's investors include leading pension funds and insurance companies.  Summer Street's investments support management buy-outs, family transitions, corporate divestitures, growth financings, and recapitalizations.  Visit www.summerstreetcapital.com for additional information.

SOURCE Summer Street Capital Partners LLC


These press releases may also interest you

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 20:39
Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New...

at 20:15
The partnership was unveiled internally at the Franchisor's annual convention in Las Vegas, NV in December 2023, eliciting...

at 19:35
Regenx Tech Corp., (the "Company" or "Regenx") is providing this bi-weekly update on the status of the application to the Alberta Securities Commission for a management cease trade order, under National Policy 12-203 -?? Management Cease Trade...

at 19:14
Kadestone Capital Corp. ("Kadestone" or the "Company") , a vertically integrated property company today announced its financial results for the year ended December 31, 2023....

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...



News published on and distributed by: